Compounding order under Section 441 of the Companies Act, 2013 for violation of Section 188 of the Companies Act, 2013 in the matter of M/s.Sun Pharmaceutical Industries Limited
In force — no superseding record on file.
File No. RD (NWR)/441/011/2024/ 034 SRN GNL-1 F98863590 Dated: 19.09.2024 BEFORE THE REGIONAL DIRECTOR (NWR), AHMEDABAD MINISTRY OF CORPORATE AFFAIRS IN THE MATTER OF :- SECTION 441 OF THE COMPANIES ACT, 2013 AND SECTION 188 OF THE COMPANIES ACT, 2013 IN THE MATTER OF :- 1. M/s. Sun Pharmaceutical Industries Limited -(Applicant No.1) 2. Mr. Dilip Shantilal Shanghvi, Chairman & MD -(Applicant No.2) FINAL ORDER pATE: _1 () DEC 2024 1. Compounding application received from:
- M/s. Sun Pharmaceutical Industries Limited -(Applicant No.1)
- Mr. Dilip Shantilal Shanghvi, Chairman & MD -(Applicant No.2) under Section 441 of the Companies Act, 2013.
Violation-Details and nature of the violation: For transactions not at Arm’s Length Basis as per the Section 188 of the Companies Act, 2013 during the F.Y.2015-16. 3. Reference of interim order: No. RD(NWR)/441/011/2024 dated 26.11.2024. 4. Compounding fee levied: Name and Designation of the | Provision Compounding fee Applicant violated for | payable by the the year. applicant (In Rs.) Mr. Dilip Shantilal Sanghvi, 2015-16 50,000/- Chairman & MD 5. Payment of Compounding fee: Name and Designation of the | Receipt details | Amount paid Applicant (InRs.) Mr. Dilip Shantilal Sanghvi, X87655734 50,000/~ Chairman & MD Dated 06.12.2024 6. Considering the facts and circumstances described in interim order dated 26.11.2024 and on account of payment of compounding fee, the compounding application bearing SRN F98863590 (GNL-1) is hereby allowed. 7.
he facts and circumstances described in interim order dated 26.11.2024 and on account of payment of compounding fee, the compounding application bearing SRN F98863590 (GNL-1) is hereby allowed. 7. Company is hereby directed to file this compounding order in prescribed E-form INC-28 with the jurisdictional ROC under the provisions of Section 441(3)(d) of the Companies Act, 2013. Dated this |Oday of December, 2024 { (G. C. YADAYV) Regional Director (NWR)(I/C) Ahmedabad To /M/s. Sun Pharmaceutical Industries Limited SPARC, Tandalja, Vadodara, Gujarat-390012. 2. Mr. Dilip Shantilal Shanghvi Tirth, New India Society No. 17, 12" Road, JVPD, Vile Parle West, Mumbai, Maharashtra - 400049. 3. Registrar of Companies, Ahmedabad, Gujarat 4. Master File 5. Office Copy
(Kamal Harjani) Joint Director For Regional Director 1|Page
Verbatim extracted text (OCR/PDF). Older scans and tables may show extraction artifacts — verify against the original for anything you act on.
No analysis generated for this document yet (analysis runs over brief docs + on-demand). Run build_analysis.py --ids 24355 --apply.